NCT00486668 2016-06-06A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast CancerNSABP Foundation IncPhase 3 Unknown529 enrolled